Schonfeld Strategic Advisors LLC Astrazeneca PLC Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 20,801 shares of AZN stock, worth $1.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,801

Previous 37,100 43.93%

Holding current value

$1.38 Million

Previous $2.89 Million 44.0%

% of portfolio

0.01%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $1.25 Million - $1.43 Million	-16,299 Reduced 43.93%	20,801 $1.62 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $27.2 Million - $32.9 Million	-406,849 Reduced 91.64%	37,100 $2.89 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $24.6 Million - $28 Million	402,615 Added 974.05%	443,949 $30.1 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $596,248 - $667,443	9,634 Added 30.39%	41,334 $2.78 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $4.25 Million - $4.7 Million	-65,600 Reduced 67.42%	31,700 $2.15 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $6.19 Million - $6.71 Million	88,516 Added 1007.7%	97,300 $6.96 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $554,709 - $628,934	8,784 New	8,784 $609,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $5.95 Million - $7.15 Million	100,483 New	100,483 $6.64 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $6.42 Million - $7.73 Million	-115,183 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $2.07 Million - $2.44 Million	-38,290 Reduced 24.95%	115,183 $6.71 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $8.29 Million - $9.07 Million	149,173 Added 3469.14%	153,473 $9.22 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $4.82 Million - $5.99 Million	-99,455 Reduced 95.86%	4,300 $258,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $4.89 Million - $5.65 Million	103,755 New	103,755 $5.16 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $1.08 Million - $1.29 Million	-22,273 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $1.18 Million - $1.36 Million	22,273 New	22,273 $1,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $5.95 Million - $8.08 Million	-157,354 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $1.03 Million - $1.23 Million	24,352 Added 18.31%	157,354 $7.85 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $4.29 Million - $4.86 Million	106,902 Added 409.59%	133,002 $5.93 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $480,912 - $537,672	-12,900 Reduced 33.08%	26,100 $1.08 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $1.38 Million - $1.68 Million	39,000 New	39,000 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $2.39 Million - $2.74 Million	-68,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $2.38 Million - $2.55 Million	68,900 New	68,900 $2.42 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Astrazeneca PLC Transaction History